OSLO, NORWAY--(Marketwired - May 7, 2013) - Algeta ASA (
The presentation will also be webcast live and can be accessed through www.algeta.com where questions can also be submitted during the presentation.
The presentation will take place at 10:00 CET at:
Haakon VIIs gate 1
Algeta's senior management will also host an international conference call at 14:30 CET/08:30 Eastern Time (US) (details below).
To participate in the conference call, please dial the appropriate number below five minutes prior to the call:
US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22
Participant pin code: 281404#
To access the replay, please dial:
US: +1 877 679 2989
UK: +44 20 3364 5196
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73
Conference reference: 346423#
A replay version of the conference call will also be available at www.algeta.com.
The results report and the presentation will be available at www.algeta.com in the Investors section from 07:00 CET.
Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (ALGETA.OL). For more information please visit www.algeta.com.
Press release: http://hugin.info/134655/R/1699187/560422.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE